STAT Plus: As efficacy of Constellation’s blood cancer drug wanes, the debate over its future ratchets higher
KEVIN MACKENZIE/UNIVERSITY OF ABERDEEN/WELLCOME
Whether the latest data on the experimental drug for myelofibrosis patients is good or bad news depends on your point of view.


No hay comentarios:
Publicar un comentario